FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDRH Prefers Guidance Comments in Table Format

[ Price : $8.95]

A new CDRH Web page on tips for providing stakeholder comments on guidance documents says the Center prefers comments that are sub...

CathVision Electrophysiology Algorithms Cleared

[ Price : $8.95]

FDA clears a CathVision 510(k) for the PVI Analyzer and Signal Complexity algorithms as part of the companys electrophysiology rec...

AstraZeneca Gets 1st OPDP 2023 Warning Letter

[ Price : $8.95]

The CDER Office of Prescription Drug Promotion warns AstraZeneca that a sales aid for its Breztri misrepresents the drugs efficacy...

Informed Consent Guidance

[ Price : $8.95]

FDA publishes a guidance on the roles of IRBs, clinical investigators, sponsors, and FDA in informed consent for clinical investig...

QS Violations at TEI Biosciences

[ Price : $8.95]

FDA warns Boston, MA-based TEI Biosciences about Quality System violations in its manufacturing of collagen-based products.

Hold Lifted on Arcellx Myeloma Drug

[ Price : $8.95]

FDA removes a partial clinical hold against an Arcellx IND for CART-ddBCMA, an investigational drug for treating patients with rel...

FDA Approves Hepzato for Uveal Melanoma

[ Price : $8.95]

FDA approves Delcath Systems Hepzato Kit (melphalan for injection/hepatic delivery system) for liver-directed treatment in adult p...

Info Collection Revision on BLA Procedures

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection revision entitled Biologics License Applications (BLAs) Proced...

Drug Compounding Registration Info Collection

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Registration of Human Drug Compounding...

FDA Denies St. Jude Codeine Use Petition

[ Price : $8.95]

FDA denies a St. Jude Childrens Research Hospital request to allow some use of codeine-containing analgesics in patients under age...